Chronic and recurrent pain rarely comes from one source. It’s usually a blend of sensitised nociception, local inflammation, reduced perfusion and guarded movement that over time erodes capacity. INDIBA® delivers capacitive–resistive monopolar radiofrequency (CRMRF) at 448 kHz, a frequency with documented physiological effects on circulation, tissue metabolism and neural sensitivity. In practice, the goal isn’t just to make pain feel lower in the room; it’s to help people move more, sooner — because movement is where durable improvement lives.
What the evidence says
Across pain conditions, PBM/RF literature shows clinically meaningful pain reductions and functional gains when energy-based therapy is paired with progressive exercise. In knee osteoarthritis (a common pain presentation), trials and syntheses report short-term improvements in pain and disability with properly dosed sessions of CRMRF or near-IR PBM — typically delivered 2× weekly over several weeks. Parameter windows described for laser PBM (e.g., 785–860 nm and 904–905 nm) are not identical to CRMRF, but the clinical pattern is similar: analgesia that supports rehab adherence.
What about 448 kHz specifically? Randomised and controlled studies examining CRET/CRMRF at 448 kHz demonstrate measurable thermal-physiological changes that map to increased perfusion and metabolic activity, consistent with mechanisms that support pain relief and recovery. A crossover study in healthy adults found sustained thermal skin adaptations after 448 kHz sessions versus pulsed shortwave therapy, indicating higher microcirculatory impact for CRMRF under matched conditions. Likewise, thermal imaging work has shown significant, lasting increases in local temperature and inferred perfusion after 448 kHz treatment of posterior thigh tissue — the sort of response you want when trying to settle irritable structures and restore motion.
In pelvic pain, an RCT reported CRMRF (INDIBA) outperformed placebo for pain reduction and quality-of-life improvement in chronic pelvic pain/bladder pain syndrome — an encouraging signal in a notoriously difficult cohort. Prospective work is also investigating radiofrequency in postpartum pelvic pain with outcomes spanning pain, sexual function and pelvic floor relaxation, reflecting growing clinical curiosity.
Where it slots into a pain pathway
- First aim: comfort and motion. We use 448 kHz sessions to reduce pain enough to re-introduce movement patterns (walking cadence work, offloaded squats, spinal control) without flares.
- Second aim: rebuild capacity. As sensitivity drops, we bias progressive loading and motor control. RF doesn’t replace exercise — it enables it.
- Review and progress. Pain scores matter, but so do functional checkpoints (sit-to-stand speed, six-minute walk, reach distance) to ensure analgesia translates to real life.
Safety, dosing and expectations
Sessions are brief, non-invasive and typically comfortable; eye protection and sensible heat monitoring are standard. We individualise capacitive vs resistive modes and total energy to tissue depth and irritability, drawing on the 448 kHz evidence base and INDIBA’s clinical guidance. Most people feel easier movement before changes in objective strength appear — which is exactly when we nudge activity up.
